In briefBMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7508.66 (Published 07 July 2005) Cite this as: BMJ 2005;331:66
Colon cancer drugs to be more widely available: The UK National Institute for Health and Clinical Excellence (NICE) has decided that two chemotherapy drugs for advanced bowel cancer, irinotecan and oxaliplatin, should be more widely available to patients. It follows a concerted campaign by Colon Cancer Concern, clinicians, patients, and other groups that have urged NICE to increase access to these …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial